Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 43: 1110-1113, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cowan, D. A.
Right arrow Articles by Kicman, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cowan, D. A.
Right arrow Articles by Kicman, A. T.
Related Collections
Right arrow Laboratory Management
Right arrow Drug Monitoring and Toxicology
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1997;43:1110-1113.)
© 1997 American Association for Clinical Chemistry, Inc.

Editorials

Doping in Sport: Misuse, Analytical Tests, and Legal Aspects

David A. Cowan and Andrew T. Kicman

Drug Control Centre, King's College London, Manresa Rd., London SW3 6LX, UK, Fax +44-171-351-2591, e-mail da.cowan@kcl.ac.uk, a.kicman@kcl.ac.uk

As part of the International Congress of Clinical Chemistry, a symposium, Doping in Sport: Misuse, Analytical Tests, and Legal Aspects, was held, a week before the start of the Olympic Games at Atlanta, bringing together a number of international experts concerned with various aspects of controlling drug abuse in sport. The presentations focused particularly on anabolic-androgenic steroids (AAS), these analytes still comprising the greatest number of positive findings in samples tested by International Olympic Committee (IOC)-accredited sports drug-testing laboratories. Although various aspects of AAS use and detection have been reported on in the last decade, the proceedings of this symposium, published in this issue of Clinical Chemistry, bring together health, social, endocrine, and analytical perspectives in a widely read peer-reviewed journal.

Those who think that the harmful effects of AAS administration are relatively benign and perhaps should not be banned by the IOC may find particularly sobering the article by Franke and Berendonk (1), which describes the health and social consequences of the clandestine state-sponsored program of administration of AAS in the former East Germany. This article should be extremely useful for educational purposes and, we hope, will encourage some present users to abandon the practice. The mechanism of action of AAS is still not well understood, and the article by Wu (2) is a useful update. Catlin et al. (3) discuss the pertinent issues of detecting AAS administration, in particular of testosterone (T), which is commonly abused. Stenman et al. (4) give a clinical chemistry perspective on the problems of detecting human chorionic gonadotropin (hCG) by immunoassay, the protein hormone that may be used by competitors to stimulate testicular production of T. Bowers (5) discusses analytical advances to detect performance-enhancing compounds, particularly with reference to xenobiotic AAS and . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
 Br. J. Sports. Med.Home page
K R Kaufman and R Gerner
Modafinil in sports: ethical considerations
Br. J. Sports Med., April 1, 2005; 39(4): 241 - 244.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.